GlobeStar Therapeutics Corp Quarterly Costs and Expenses in USD for Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
GlobeStar Therapeutics Corp quarterly/annual Costs and Expenses history and growth rate for Q4 2023.
  • GlobeStar Therapeutics Corp Costs and Expenses for the quarter ending December 31, 2023 was $42.2K.
Costs and Expenses, Quarterly (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2023 $42.2K Oct 1, 2023 Dec 31, 2023 10-Q 2024-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.